rosiglitazone has been researched along with Bone Marrow Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benko, I; Benko, K; Djazayeri, K; Rózsa, B; Szabó, B; Szentmiklósi, AJ; Szilvássy, Z | 1 |
1 other study(ies) available for rosiglitazone and Bone Marrow Diseases
Article | Year |
---|---|
Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Bone Regeneration; Female; Fluorouracil; Granulocytes; Hypoglycemic Agents; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrophils; Rosiglitazone; Thiazolidinediones | 2006 |